BIOTRONIK Study Assesses Innovative Intracardiac Impedance Sensing Technology for CRT Optimization

New heart failure sensor expected to provide physicians with critical information about patients’ conditions and disease progressionBERLIN, Germany, November 28, 2012—BIOTRONIK , a leading manufacturer of innovative medical technology, today announced that the first patient has been enrolled in the company’s BIO.Detect HF II study. The study’s goal is to investigate the clinical relevance of the innovative intracardiac impedance (ICI) sensing technology and its ability to assess hemodynamic parameters. The ICI technology is